Reduced plasma orexin-A levels in patients with bipolar disorder
Shoko Tsuchimine,1 Kotaro Hattori,1 Miho Ota,1 Shinsuke Hidese,1 Toshiya Teraishi,1 Daimei Sasayama,1 Hiroaki Hori,1 Takamasa Noda,2 Sumiko Yoshida,2 Fuyuko Yoshida,1 Hiroshi Kunugi11Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiat...
Saved in:
Main Authors: | Tsuchimine S, Hattori K, Ota M, Hidese S, Teraishi T, Sasayama D, Hori H, Noda T, Yoshida S, Yoshida F, Kunugi H |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/6823340e0a4342fb8ccdaf4e55c9efe0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
by: Borjanka Batinic, et al.
Published: (2021) -
Comparing the Self- and External Assessment Versions of the HCL-33 as Screening Instruments for Bipolar Disorder in Older Depressed Patients
by: Xinqiao Zhang, et al.
Published: (2021) -
When should a psychiatrist remember to test homocysteine levels? - a literature review
by: Nowak Katarzyna, et al.
Published: (2021) -
Tumor cell apoptosis mediated by the orexins
by: A. S. Diatlova, et al.
Published: (2021) -
Prevalence of Comorbid Anxiety Disorders and Their Associated Factors in Patients with Bipolar Disorder or Major Depressive Disorder
by: Inoue T, et al.
Published: (2020)